[Effect of a beta-glucuronidase inhibitor (2,5-di-O-acetyl-D-glucuro-diláctone and sodium D-glucurolactonate) on rheumatoid arthritis].
D000284:Administration, Oral; D000328:Adult; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000201:enzymology; D005260:Female; D005966:Glucuronidase / Q000037:antagonists & inhibitors* / Q000097:blood; D006801:Humans; D007270:Injections, Intra-Articular; D007783:Lactones / Q000627:therapeutic use*; D013582:Synovial Fluid / Q000201:enzymology
D007783:Lactones; D005966:Glucuronidase